Search

Laszlo Te Nadasdi

from Oakland, CA
Age ~78
Get Report
Also known as:
Laszlo T Nadasdi, Laszlo Adasd, Laszio Nadasdi, Laslo Nadasdi, Nadasdi Laszlo, Laszlo I
Phone and address:
6253 Fairlane Dr, Oakland, CA 94611
(510) 655-8531
Related to:
Orsolya Nadasdi
Connected to:
Andrea Nadasdi, 60Mark L Nadasdy, 64Gretchen E Nadasky, 56Robert Nadasky, 86Gopalan J Nadathur, 69Eileen Nadaud, 63Philip T Nadavallil, 52Istvan Naday, 77Laszlo L Naday, 73David P Nadboralski, 44

Laszlo Nadasdi Phones & Addresses

  • 6253 Fairlane Dr, Oakland, CA 94611 (510) 655-8531 (510) 325-7559
  • Piedmont, CA
  • Walnut Creek, CA
  • San Francisco, CA
  • South San Francisco, CA
  • Sterling Heights, MI
  • Alameda, CA
  • 6253 Fairlane Dr, Oakland, CA 94611

Work

Position: Protective Service Occupations

Education

Degree: Bachelor's degree or higher

Publications

Us Patents

Peptidyl Calcium Channel Blockers

View page
US Patent:
6423689, Jul 23, 2002
Filed:
Dec 16, 1998
Appl. No.:
09/212785
Inventors:
Richard John Booth - Ann Arbor MI
Louis Brogley - Santa Cruz CA
Wayne Livingston Cody - Saline MI
David Thomas Connor - Ann Arbor MI
Harriet Wall Hamilton - Chelsea MI
John Xiaoqiang He - Indianapolis IN
Leonard Joseph Lescosky - Ann Arbor MI
Thomas Charles Malone - Canton MI
Laszlo Nadasdi - Oakland CA
Michael Francis Rafferty - Ann Arbor MI
Bruce David Roth - Plymouth MI
Diego F. Silva - Burlingame CA
Yuntao Song - Ann Arbor MI
Balazs G. Szoke - Palo Alto CA
Laszlo Urge - Menlo Park CA
Assignee:
Warner-Lambert Company - Morris Plains NJ
Neurex Corporation - Menlo Park CA
International Classification:
A61K 3805
US Classification:
514 19, 540483, 540607, 544159, 544168, 544391, 546221, 546224, 546233, 5483381, 548538, 548557, 548568, 548953, 548966, 564153, 564155, 564157
Abstract:
The present invention provides compounds that block calcium channels having the Formula I shown below. The present invention also provides methods of using the compounds of Formula I to treat stroke, cerebral ischemia, head trauma, or epilepsy and to pharmaceutical compositions that contain the compounds of Formula I.

Analgesic Screening Method And Composition

View page
US Patent:
6489119, Dec 3, 2002
Filed:
Dec 6, 1999
Appl. No.:
09/454714
Inventors:
James L. Miller - Los Altos CA
George P. Miljanich - Redwood City CA
Stephen S. Bowersox - Menlo Park CA
Laszlo Nadasdi - Walnut Creek CA
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C12Q 100
US Classification:
435 71, 435 4, 435 72, 435 721, 435967, 436 8, 436 63, 436149, 436501, 436806, 436815, 424 91, 424 92, 5142378, 5142388, 514255, 514315, 514567, 514626, 514428, 514613, 564194
Abstract:
Disclosed is a method of selecting analgesic agents based on their selective ability to block tetrodotoxin-insensitive sodium channels, particularly in comparison to blocking tetrodotoxin-sensitive sodium channels. Also disclosed is a novel class of compounds that is selective for blocking tetrodotoxin-insensitive sodium channels.

Voltage-Gated Calcium Channel Antagonist And Method

View page
US Patent:
6653460, Nov 25, 2003
Filed:
Aug 16, 2000
Appl. No.:
09/640957
Inventors:
Robert Newcomb - Palo Alto CA
Andrew L. Palma - San Ramon CA
Balazs G. Szoke - Palo Alto CA
Katalin Tarczy-Hornoch - Berkeley CA
William F. Hopkins - Mountain View CA
Ruth L. Cong - Fremont CA
George P. Miljanich - Redwood City CA
Robin Dean - Mountain View CA
Laszlo Nadasdi - Walnut Creek CA
Laszlo Urge - Berkeley CA
Stephen Scott Bowersox - Menlo Park CA
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C07H 2102
US Classification:
536 231, 536 2433, 435 6, 435 701, 530300, 530324, 530858, 514 12, 514 21
Abstract:
A novel class of peptides selectively block class E voltage-gated calcium channels. The class is exemplified by HG peptides such as HG-1, which is isolated from the venom-producing cells of the tarantula Hysterocrates gigas. Also disclosed are methods of producing blocking class E channels using the peptides. HG peptides have utility, for example, in inhibiting oxytocin release and for use as anticonvulsants.

Analgesic Screening Method And Composition

View page
US Patent:
20030040028, Feb 27, 2003
Filed:
Oct 22, 2002
Appl. No.:
10/277444
Inventors:
James Miller - Los Altos CA, US
George Miljanich - Redwood City CA, US
Stephen Bowersox - Menlo Park CA, US
Laszlo Nadasdi - Walnut Creek CA, US
International Classification:
G01N033/53
G01N033/567
US Classification:
435/007210
Abstract:
Disclosed is a method of selecting analgesic agents based on their selective ability to block tetrodotoxin-insensitive sodium channels, particularly in comparison to blocking tetrodotoxin-sensitive sodium channels. Also disclosed is a novel class of compounds that is selective for blocking tetrodotoxin-insensitive sodium channels.

Compounds For Pim Kinase Inhibition And For Treating Malignancy

View page
US Patent:
20100160297, Jun 24, 2010
Filed:
Nov 11, 2009
Appl. No.:
12/616581
Inventors:
Karoly Nikolich - Emerald Hills CA, US
Laszlo Nadasdi - Oakland CA, US
Tanjew Dittgen - Heidelberg, DE
Armin Schneider - Heidelberg, DE
International Classification:
A61K 31/551
C07D 243/08
C07D 401/12
C12N 9/99
A61K 31/497
A61P 35/00
A61P 35/02
US Classification:
514218, 540575, 544363, 435184, 51425217
Abstract:
The present invention relates to the compounds of formula I as well as to their use as PIM kinase inhibitors and, thereby, their use for treating oncological diseases, particularly of the hematopoietic system, the liver and the prostate gland.

Compounds For Improving Learning And Memory

View page
US Patent:
20110237600, Sep 29, 2011
Filed:
May 11, 2009
Appl. No.:
12/991839
Inventors:
Karoly Nikolich - Emerald Hills CA, US
Laszlo Nadasdi - Oakland CA, US
International Classification:
A61K 31/496
C07D 401/12
A61P 25/00
A61P 25/18
A61P 25/22
A61P 25/24
A61P 25/28
US Classification:
51425305, 544363
Abstract:
The present invention provides a compound of Formula I: (I) and methods for improving memory in a subject by administering a therapeutically effective amount of the compound.

Compounds For Rho Kinase Inhibition And For Improving Learning And Memory

View page
US Patent:
20110294789, Dec 1, 2011
Filed:
May 11, 2009
Appl. No.:
12/991846
Inventors:
Karoly Nikolich - Emerald Hills CA, US
Laszlo Nadasdi - Oakland CA, US
International Classification:
A61K 31/5513
A61P 25/24
A61P 25/22
A61P 25/00
A61K 31/497
C07D 401/10
US Classification:
514218, 51425305, 540575, 544363
Abstract:
The present invention provides a compound of Formula (I) and methods for improving memory, inhibiting rho kinase 1 or 2, inhibiting PIM kinase, or inhibiting IRAK1 kinase in a subject by administering a therapeutically effective amount of the compound.

Voltage-Gated Calcium Channel Antagonist And Method

View page
US Patent:
61567264, Dec 5, 2000
Filed:
Aug 1, 1997
Appl. No.:
8/904431
Inventors:
Robert Newcomb - Palo Alto CA
Andrew L. Palma - San Ramon CA
Balazs G. Szoke - Palo Alto CA
Katalin Tarczy-Hornoch - Berkeley CA
William F. Hopkins - Mountain View CA
Ruth L. Cong - Fremont CA
George P. Miljanich - Redwood City CA
Robin Dean - Mountain View CA
Laszlo Nadasdi - Walnut Creek CA
Laszlo Urge - Berkeley CA
Stephen Scott Bowersox - Menlo Park CA
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K 3802
A61K 3817
C07K 200
C07K 14435
US Classification:
514 12
Abstract:
A novel class of peptides selectively block class E voltage-gated calcium channels. The class is exemplified by HG peptides such as HG-1, which is isolated from the venom-producing cells of the tarantula Hysterocrates gigas. Also disclosed are methods of producing blocking class E channels using the peptides. HG peptides have utility, for example, in inhibiting oxytocin release and for use as anticonvulsants.
Control profile
Laszlo Te Nadasdi from Oakland, CA, age ~78 Get Report